Researchers Examine Etiology of Ibrutinib Discontinuation in CLL
Poor prognosis after discontinuation for disease progression, especially Richter's transformation
ASCO: High-Risk Prostate Cancer Diagnosis Up Since New PSA Recs
Researchers report 3 percent annual rise in intermediate- and high-risk cases
Location of Colorectal Cancer Factors Into Survival
Poorer outcome seen in study when tumor began on the organ's right side
Suicide Deemed Public Health Concern in Genitourinary Cancers
Risk factors include male gender, distant disease, increasing age, race/ethnicity
Six-Month Dual Antiplatelet Tx Noninferior to 24-Month DAPT
Findings show noninferiority for six-months of treatment in aspirin-sensitive patients
Nasal Allergies Tied to Increased Nasopharyngeal Cancer Risk
Even higher risk seen for patients with repeated visits for allergic rhinitis
ASCO: Testicular Cancer May Raise Risk of Prostate Cancer
But it's too soon to make any recommendations, and overall risk is low, researcher says
ASCO: Survival Down in Some Cases of Active Surveillance
Lower survival for intermediate-risk disease, compared to low-risk cases
SNP Linked to Vincristine-Related Neuropathy in ALL
SNP in promoter region of CEP72 gene linked to risk and severity of neuropathy in children with ALL
FDA Approves Farydak for Multiple Myeloma
Drug is sanctioned for people who have received at least two prior standard therapies
